Programming – Vascular Discovery 2024

Vascular Discovery 2024 Schedule-at-a-Glance

All times are Central Daylight Time (CDT, GMT -5)

Wednesday, May 15

Wed., May 15 schedule
Time Activity
8:00 a.m. – 6:00 p.m. Vascular Research Initiatives Conference(link opens in new window)
This event is not part of the official Vascular Discovery Scientific Sessions as planned by the Program Committee.
Separate registration is required to attend.

3:00 p.m. – 7:00 p.m. Vascular Discovery Scientific Sessions Registration
6:30 p.m. – 8:00 p.m. Poster Session 1 & Reception

Thursday, May 16

Thu., May 16 schedule
Time Activity
7:00 a.m. to 8:00 a.m. Registration, Breakfast, Exhibits
7:00 a.m. to 8:00 a.m. Early Career Training Session 1 – Academic Roundtables

7:00 - Getting Your Training Grant Funded
Bishuang Cai, PhD, Icahn School of Medicine at Mt. Sinai
Casey Romanoski, PhD, The University of Arizona

7:00 - Saying No and Difficult Conversations
Robert Bauer, PhD, Columbia University
Jaume Amengual, PhD, University of Illinois

7:00 - Setting Up Your Lab, Hiring and Switching Universities
Brian Kim, MD, Stanford University

7:00 - The Importance of Mentoring and Being Mentored
Mabruka Alfaidi, MD, PhD, LSU Health Sciences Center-Shreveport
Jesse Williams, PhD, University of Minnesota Medical School

7:00 - Work-Life Balance
Mireille Ouimet, PhD, University of Ottawa Heart Institute
Gregory Payne, MD, PhD, University of Alabama at Birmingham

7:00 - Strategies for Project Management
Cynthia St. Hillaire, PhD, FAHA, University of Pittsburgh

8:00 a.m. to 8:30 a.m.

Conference Opening Welcome

8:00 Welcome Remarks from AHA President
Joseph C. Wu, MD, PhD, FAHA, Stanford University

8:15 Welcome Remarks from the Program Chair
Kathleen Martin, PhD, Yale University

8:30 a.m. to 10:00 a.m.

Plenary Session 1: Hot Topics in Cardiovascular Disease

8:30 Complementing Human Organoids for Vascular Discovery
Takanori Takebe, MD, PhD, Cincinnati Children’s Hospital Medical Center

9:00 Clonal hematopoiesis, aging, and CVD
Kenneth Walsh, PhD, FAHA, University of Virginia

9:30 Title TBA
Minna Kaikkonen-Maata, PhD, A.I.Virtanen Institute, University of Eastern Finland

10:00 a.m. to 10:30 a.m. BREAK/Exhibits
10:30 a.m. to 12:15 p.m.

Concurrent Session 1a: Molecular and Cellular Mechanisms of Atherosclerosis

10:30 Title TBA
Muredach Reilly, MD, Columbia University

11:00 Oral Abstract Presentations

10:30 a.m. to 12:15 p.m.

Concurrent Session 1b: Inflammation & Immunity in the Vessel Wall

10:30 Macrophages in Aortic Aneuysm
Bo Liu, PHD, University of Wisconsin-Madison

11:00 Oral Abstract Presentations

10:30 a.m. to 12:15 p.m.

Concurrent Session 1c: Endothelial Dysfunction in Thrombosis

10:30 Regulation of Endothelial Procoagulant Activity by TMEM16 Proteins
Alec Schmaier, MD, PhD, Beth Israel Deaconess Medical Center

10:50 Genetic analysis of endothelial protease-activated receptors in disease contexts
Courtney Griffin, PhD, Oklahoma Medical Research Foundation

11:10 Presentation Title: TBD
Hasina Outtz-Reed, MD, PhD, Weill Cornell Medicine

11:30 Oral Abstract Presentations

12:15 p.m. to 2:00 p.m. The Mentor of Women Award Luncheon  - Presented by the ATVB Women's Leadership Committee (ticket required)

12:15 - Networking

12:30 - Thriving as Internationally Trained Scholars
Elena Aikawa, MD, PhD, Brigham and Women’s Hospital
Masanori Aikawa, MD, PhD, Brigham and Women’s Hospital

1:10 - Round Table Discussions
Masanori Aikawa, MD, PhD, Brigham and Women’s Hospital
Yabing Chen, PhD, University of Alabama at Birmingham
Alan Daugherty, PhD, University of Kentucky College of Medicine
Muredach Reilly, MD, Columbia University
Phil Tsao, PhD, Stanford University
Daisy Sahoo, PhD, Medical College of Wisconsin
Gissette Reyes-Soffer, MD, Columbia University
Shashi Kant, PhD, Harvard Medical School
Anberitha Matthews, PhD, Redefining Health

1:50 - Networking

or
PVD Annual Business Meeting & and Business Luncheon (ticket required)
Offiste at the Chicago Firehouse

or
Lunch on your own

2:15 p.m. to 3:45 p.m.  Plenary Session 2: Highlights from the ATVB Journal

2:15 - ATVB Journal Update
Ann Marie Schmidt, MD, NYU Langone Health

2:30 - Daniel Steinberg Early Career Investigator Award in Atherosclerosis/Lipoproteins: Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis
Partha Dutta, DVM, PhD, University of Pittsburgh

2:45 - Karl Link Early Career Investigator Award in Thrombosis: Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels Gut Bacterial Metabolism and Cardiometabolic Disease
Maria Sabater-Lleal, PhD, Research Institute Hospital de la Santa Creu

3:00 - Werner Risau Early Career Investigator Award in Vascular Biology: Dedifferentiation and Proliferation of Artery Endothelial Cells Drive Coronary Collateral Development in Mice
Soumyashree Das, PhD, National Centre for Biological Sciences

3:15 - Presentation Title: TBA
Luisa Ireula-Arispe, PhD, Northwestern University Feinberg School of Medicine

3:45 p.m. to 4:15 p.m. Break/Exhibits 
4:15 p.m. to 6:00 p.m.

Concurrent Session 2a: Apolipoproteins, Lipoproteins, and Lipid Metabolism

4:15 Massively Parallel Interrogation of Lipoprotein Uptake Modifiers
Brian Emmer, MD, PhD, University of Michigan

4:45 Oral Abstract Presentations

4:15 p.m. to 6:00 p.m.

Concurrent Session 2b: Thrombosis: Signaling, Mechanisms and Function

4:15 Targeting Neutrophils in Immunothrombosis
Lalitha Nayak, MD, Case Western Reserve University 

4:45 Oral Abstract Presentations

4:15 p.m. to 6:00 p.m.

Concurrent Session 2c: Investigator in Training Award Oral Abstract Competition
and Hot Off The Bench Oral Abstract Presentations

6:00 p.m to 7:30 p.m.

Poster Session 2 & Reception
Sponsored by the ATVB Journal 


Friday, May 17

Fri., May 17 schedule
Time Activity
7:00 a.m. Registration, Breakfast & Exhibits
7:00 a.m. to 8:00 a.m. Early Career Training Session 2 – Academic Success Stories (Panel Discussion)

7:00 - Panel Discussants
Jeff Hsu, MD, PhD, UCLA Health
Christina Espinosa-Diez, PhD, Wayne State School of Medicine
Colin Evans, PhD, University of South Carolina
Ada Weinstock, PhD, University of Chicago

8:00 a.m. to 9:30 a.m.

Plenary Session 3: Advances in Cardiometabolic Disease

8:00 Presentation title TBA
Zoltan Arany, MD, PhD, University of Pennsylvania

8:30 16 Years of GWAS - From a Single Locus to 393 Genome-wide Significant CAD Associations
Ruth McPherson, MD, PhD, FRCPC, University of Ottawa Heart Institute

9:00 Gut Bacterial Metabolism and Cardiometabolic Disease
Federico E. Rey, PhD, University of Wisconsin-Madison

9:30 a.m. to 10:00 a.m. BREAK/Exhibits
10:00 a.m. to 11:45 a.m.

Concurrent Session 3a:  Therapeutic Targets in Atherosclerosis

10:00 Enhanced endothelial cell retention within tissue engineered vascular grafts
Brandon Tefft, PhD, Medical College of Wisconsin

10:30 Oral Abstract Presentations

10:00 a.m. to 11:45 a.m.

Concurrent Session 3b: Blood Coagulation in Health & Disease

10:00 Presentation title TBA
Nirav Dhanesha, PhD, LSU Health

10:30 Oral Abstract Presentations

10:00 a.m. to 11:45 a.m.

Concurrent Session 3c: Carotid Artery Disease

10:00 Presentation title TBA
Wei Zhou, MD, University of Arizona

10:20 Presentation title TBA
Santhi Ganesh, MD, University of Michigan

10:40 Exploring Carotid Plaque Instability: a BIKE-ride from Identification of Molecular Disease Targets to Improved Stroke-risk Prediction
Ulf Heden, MD, PhD, Karolinska University Hospital & Karolinska Institute

11:00 Endothelial Dysfunction in Carotid Atherothrombosis and Stroke
Kathryn Howe, MD, PhD, FRCSC, University Health Network, Peter Munk Cardiac Centre

11:20 Oral Abstract Presentations

11:45 a.m. to 1:45 p.m. ATVB Diversity Committee Luncheon: Diversity and inclusion in the workplace: institutional support and legislative changes
12:45 a.m. to 1:45 p.m. Lunch on your own
1:45 p.m. to 3:45 p.m. Plenary Session 4:  Early Career Investigator Award Competition: Brinkhous Prize and Page Jr Faculty Research Award
3:45 p.m. to 4:15 p.m. Break/Exhibits
4:15 p.m to 6:00 p.m.

Concurrent Session 4a:  Metabolic Disorders in Atherosclerosis - Organized in cooperation with the Chinese International Congress of Vascular Medicine

4:15 Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases
Changtao Jiang, MD, PhD, Peking University Health Science Center

4:45 Comprehensive Management of Metaboic Vascular Disease - 20 Years Vascular Health Promotion in China
Hongyu Wang, MD, PhD, FASH, Peking University Shougang Hospital

5:15 Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease
Kaizheng Gong, MD, PhD, Affiliated Hospital of Yangzhou University

5:30 Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy
Chaoping Yu, MD, The Third Affiliated Hospital of Chengdu Medical College

5:45 Oral Abstract Presentations

4:15 p.m to 6:00 p.m.

Concurrent Session 4b: Vascular Cells, Inflammation and Thrombosis

4:15 Cardiovascular Calcification
Cynthia St. Hilaire, PhD, FAHA, University of Pittsburgh

4:45 Oral Abstract Presentations

4:15 p.m to 6:00 p.m.

Concurrent Session 4c: Genomics and Multi-Omics in Vascular Disease

4:15 Presentation Title TBA
Catherine Tcheandjieu, DVM, PhD, Gladstone Institutes

4:45 Presentation title TBA
Clint Miller, PhD, University of Virginia

5:15 Oral Abstract Presentations

6:00 p.m. to 7:30 p.m.

Poster Session 3 and Reception

7:30 p.m. to 10:00 p.m.

Joint Council Dinner
Ticket Required to attend


Saturday, May 18

Sat., May 18 schedule
Time Activity
7:00 a.m. to 12:00 p.m. Registration
7:00 a.m. to 8:30 a.m. Continental Breakfast
8:30 a.m. to 10:00 a.m.

Plenary Session 5: Cardio-oncology: The Role of the Vasculature

8:30 Cardio-oncology Through a Vascular Lens
Iris Jaffe, MD, PhD, Tufts Medical Center

9:00 Racial Disparites in Cardio-oncology - Defining Differences in Endothelial Function in Reponse to Anti-Cancer Therapy
Andreas Beyer, PhD, Medical College of Wisconsin

9:30 Presentation title TBA
Carl Ade, PhD, Kansas State University

9:45 Oral Abstract Presentations

10:00 a.m. to 10:15 a.m. BREAK/Exhibits
10:15 a.m. to 12:15 p.m.

Plenary Session 6: Invited Lecture Series

10:15 Hoeg Award Lecture
TBA

10:45 Keynote Lecture
Kristy R. Red-Horse, PhD, Howard Hughes Medical Institute/Stanford University

11:15 Distinguished Lecture: Targets for New Anticoagulants: XI Before XII
Jeffrey Weitz, MD, FAHA, FRCPC, FACP, FRSC, FACC, FESC, FCAHS, McMaster University, Thrombosis and Atherosclerosis Research Institute

11:45 PVD Mid-Career Award Lecture

12:15 p.m. Closing Remarks / Adjourn

Keynote Lecture and Distinguished Lecture Speakers

Keynote Lecture
Kristy Red-Horse, PhD

Kristy Red-Horse, PhD

Invited Lecture Series
Presentation Title: TBD

Kristy Red-Horse is a Professor at Stanford University’s Department of Biology and Institute for Stem Cell Biology & Regenerative Medicine. She is also an Investigator with the Howard Hughes Medical Institute. Her PhD research explored how the vasculature of the placenta incorporates within the uterine arterial network. As a postdoc at Stanford, Dr. Red-Horse identified the progenitors of coronary arteries in mouse hearts. In her own lab, she and her team went on to explore many different aspects of how coronary arteries develop from these progenitors. The Red-Horse group also studies how coronaries regenerate and respond to injury, and devises methods for increasing their growth to enhance cardiac recovery. Dr. Red-Horse has received awards such as the NIH Pathway to Independence Award (K99/R00) and the Searle Scholar’s Award. She was also a New York Stem Cell Foundation—Robertson Investigator and received the Judah Folkman Award in vascular biology. In 2021, Dr. Red-Horse was named a Howard Hughes Investigator. In 2023, Dr. Red-Horse became a member of the National Academy of Medicine.

Distinguished Lecture
Jeffrey Weitz, MD, FAHA, FRCPC, FRSC, FACP

Jeffrey Weitz, MD, FAHA, FRCPC, FRSC, FACP

Invited Lecture Series
Presentation Title: Targets for new anticoagulants: XI before XII

Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute and Past President of Council for the International Society on Thrombosis and Haemostasis. Board Certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy. The breadth of his work is highlighted by his over 640 publications in journals as diverse as the Journal of Clinical Investigation, Journal of Biological Chemistry, Biochemistry, Circulation, Blood, Annals of Internal Medicine, New England Journal of Medicine and Lancet, and 76 book chapters. The recipient of numerous awards, Dr. Weitz was appointed as an Officer of the Order of Canada and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.

Vascular Discovery 2024
Invited Speakers

Carl Ade

Carl Ade, PhD

Session: Cardio-oncology: the Role of the Vasculature
Presentation Title: TBD
Zoltan Arany

Zoltan Arany, MD, PhD

Session: Advances in Cardiometabolic Disease
Presentation Title: TBD
Andreas Beyer, PhD, Medical College of Wisconsin

Andreas Beyer, PhD

Session: Cardio-oncology – The Role of the Vasculature
Presentation Title: Racial disparities in cardio-oncolgy – Defining Differences in Endothelial Function in Response to Anti-Cancer Therapy
Zachary Clayton

Zachary Clayton, PhD

Session: Cardio-oncology: the Role of the Vasculature
Presentation Title: Anthracycline chemotherapy-mediated vascular dysfunction: Understanding basic mechanisms to inform future clinical therapies
Nirav Dhanesha, PhD

Nirav Dhanesha, PhD

Session: Blood Coagulation in Health and Disease
Presentation Title: TBA
Brian Emmer, MD, PhD

Brian Emmer MD, PhD

Session: Apolipoproteins, Lipoproteins and Lipid Metabolism
Presentation Title: Massively Parallel Interrogation of Lipoprotein Uptake Modifiers
Santhi Ganesh

Santhi Ganesh, MD

Session: Carotid Artery Disease
Presentation Title: TBD
Chiara Giannareli, MD, PhD

Chiara Giannareli, MD, PhD

Session: Inflammation and Immunity in the Vessel Wall
Presentation Title: TBD
Courtney Griffin

Courney Griffin, PhD

Session: Endothelial Dysfunction in Thrombosis
Presentation Title: Genetic analysis of endothelial protease-activated receptors in disease contexts
Kaizheng Gong, MD, PhD

Kaizheng Gong, MD, PhD

Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular Medicine
Presentation Title: Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease
Ulf Hedin

Ulf Hedin, MD, PhD

Session: Carotid Artery Disease
Presentation Title: Exploring carotid plaque instability: a BiKE-ride from identification of molecular disease targets to improved stroke-risk prediction
Kathryn Howe

Kathryn L Howe MD, PhD, FRCSC

Session: Carotid Artery Disease
Presentation Title: Endothelial Dysfunction in Carotid Atherothrombosis and Stroke
Iris Jaffe

Iris Jaffe, MD, PhD

Session: Cardio-oncology the Role of the Vasculature
Presentation Title: Cardio-oncology Through a Vascular Lens 
Changtao Jiang, MD, PhD

Changtao Jiang, MD, PhD

Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular Medicine
Presentation Title: Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases
Minna Kaikkonen

Minna Kaikkonen, PhD

Session: Hot Topics in Cardiovascular Disease
Presentation Title: TBD
Bo Liu, PhD, University of Wisconsin-Madison

Bo Liu, PhD

Session: Inflammation & Immunity in the Vessel Wall
Presentation Title: Macrophages in Aortic Aneurysm
Ruth McPherson, MD

Ruth McPherson, MD, PhD, FRCPC

Session: Advances in Cardiometabolic Disease
Presentation Title: 16 years of GWAS – From a Single Locus to 393 Genome-wide Significant CAD Associations
Clint L. Miller

Clint Miller, PhD

Session: Genomics and Multi-Omics in Vascular Disease
Presentation Title: TBD
Lalitha Nayak, MD

Lalitha Nayak, MD

Session: Thrombosis, Signaling Mechanisms, & Function
Presentation Title: Targeting Neutrophils in Immunothrombosis
Hasina Outtz Reed, MD, PhD

Hasina Outtz Reed, MD, PhD

Session: Endothelial Dysfunction in Thrombosis
Presentation Title: TBD
Muredach Reilly, MD

Muredach Reilly, MD

Session: Molecular and Cellular Mechanisms of Atherosclerosis
Presentation Title: TBD
 
Federico E. Rey, MD

Federico E. Rey, PhD

Session: Advances in Cardiometabolic Disease
Presentation Title: Gut Bacterial Metabolism and Cardiometabolic Disease
Alec Schmaier

Alec A. Schmaier, MD, PhD

Session: Endothelial Dysfunction in Thrombosis
Presentation Title: Regulation of endothelial procoagulant activity by TMEM16 proteins
Cynthia St. Hilaire, PhD, FAHA

Cynthia St. Hilaire, PhD, FAHA

Session: Vascular Cells, Inflammation and Thrombosis
Presentation Title: Cardiovascular Calcification
Takanori Takebe

Takanori, Takebe, MD, PhD

Session: Hot Topics in Cardiovascular Disease
Presentation Title: Complementing Human Organoids for Vascular Discovery
Catherine Tcheandjieu, DVM, PhD

Catherine Tcheandjieu, DVM, PhD

Session: Genomics and Multi-Omics in Vascular Disease
Presentation Title: TBD
Brandon Tefft, PhD

Brandon Tefft, PhD

Session: Therapeutic Targets in Atherosclerosis
Presentation Title: Enhanced endothelial cell retention within tissue engineered vascular grafts
Kenneth Walsh, PhD

Kenneth Walsh, PhD

Session: Hot Topics in Cardiovascular Disease
Presentation Title: Clonal Hematopoiesis, Aging, and CVD
Hongyu Wang, MD, PhD, FASH

Hongyu Wang, MD, PhD

Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular Medicine
Presentation Title: Comprehensive Management of Metabolic Vascular Disease: 20 Years Vascular Health Promotion in China
Chaoping Yu, MD, The 3rd Affiliated Hospital of Chengdu Medical College

Chaoping Yu, MD

Session: Metabolic Disorders in Atherosclerosis
Presentation Title: Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy
Wei Zhou

Wei Zhou, MD

Session: Carotid Artery Disease
Presentation Title: TBD

About this Meeting

This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.

Vascular Discovery 2024 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.

See the American Heart Association Policies and Guiding Values (PDF).

Target Audience

The conference will especially appeal to scientists and clinicians interested in: 

  • Allergy and Immunology
  • Arteriosclerosis
  • Biochemistry
  • Biological Sciences
  • Diabetes and Metabolism
  • Functional Genomics
  • Genetics
  • Hematology
  • Internal Medicine
  • Molecular/Cellular Biology
  • Nutrition
  • Pathology
  • Peripheral Artery Disease
  • Pharmacology
  • Physiology
  • Vascular Surgery
  • Thrombosis
  • Vascular Biology
  • Vascular Medicine

Learning Objectives

At the conclusion of this conference, participants will be able to:

  1. Discuss recent advances and emerging experimental models in ATVB and peripheral vascular diseases that target primary acquired diseases and/or secondary factors contributing to vascular-related disorders.
  2. Summarize findings from recent translational research or clinical trials and the impact for future treatment and/or management of vascular-related disorders.
  3. Describe best practices associated with ATVB scientific research and/or the management of patients with vascular-related diseases.